Supplementary Figure S1 from Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity from a Phase I Study of Simlukafusp Alfa (FAP-IL2v) in Advanced/Metastatic Solid TumorsNeeltje Steeghs,Carlos Gomez-Roca,Kristoffer S. Rohrberg,Morten Mau-Sørensen,Debbie Robbrecht,Josep Tabernero,Samreen Ahmed,Maria E. Rodríguez-Ruiz, Caroline Ardeshir, Daniela Schmid, Nassim Sleiman,Carl Watson, Hanna Piper-Lepoutre,David Dejardin,Stefan Evers,Christophe Boetsch,Jehad Charo,Volker Teichgräber,Ignacio Melerocrossref（2024）引用 0|浏览13暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
